White noise a non pharmacological treatment of gastroesophageal reflux in newborn babies

White noise alleviates gastroesophageal reflux in newborn babies: a randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061767

Enrollment

Unknown

Registered

2022-07-02

Start date

2020-09-01

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease

Interventions

experimental group:white noise exposure

cotrol group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newborn babies (gender male and female, age 30-50 days) with and without symptoms of gastroesophageal reflux disease GERD.

Exclusion criteria

Exclusion criteria: Newborn babies (gender male and female, age 30-50 days) with diseases symptoms other then gastroesophageal reflux disease symptoms.

Design outcomes

Primary

Measure	Time frame
reduces the frequency of gastric reflux;	—

Secondary

Measure	Time frame
reduce the time for the babies to fall asleep;	—

Countries

Lebanon

Contacts

Public ContactHussein MOUAWIA

Faculty of Public Health Lebanese University

houssein.mouawia@ul.edu.lb+961 37865353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026